Otsuka America Pharmaceutical, Inc.

Registered Principal Details

Business Or Interest:
Pharmaceutical manufacturer

Lobbying Interests:
All matters related to healthcare and pharmaceuticals.

CEO Name:
Tarek Rabah

Contact
TF
Thomas Foulkes
2440 Research Boulevard
Rockville, MD 20850
202-340-0884
Thomas.Foulkes@otsuka-us.com
http://www.otsuka-us.com

Authorized Lobbyists

Lobbyist Name Exclusive Duties Authorized On Withdrawn On
Brittany Duffy Exclusive Duties No Authorized On 12/23/2022 Withdrawn On N/A
Jordan Lamb Exclusive Duties No Authorized On 1/4/2023 Withdrawn On N/A

Lobbying Interests

Legislative Bills/Resolutions

Assembly Bill 103
Assembly Bill 103
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.

Bill Text and History

For
Notification Date
3/17/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 654
Assembly Bill 654
Relating to: utilization management controls for prescription drugs to treat mental illness under the Medical Assistance program. (FE)

Bill Text and History

For
Notification Date
11/28/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Bill 773
Assembly Bill 773
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
12/11/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Joint Resolution 111
Assembly Joint Resolution 111
Relating to: observing February 29, 2024, as Rare Disease Day in Wisconsin.

Bill Text and History

For
Notification Date
1/29/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Assembly Resolution 3
Assembly Resolution 3
Relating to: observing February 28, 2023, as Rare Disease Day in Wisconsin.

Bill Text and History

For
Notification Date
3/10/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 100
Senate Bill 100
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.

Bill Text and History

For
Notification Date
3/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 618
Senate Bill 618
Relating to: utilization management controls for prescription drugs to treat mental illness under the Medical Assistance program. (FE)

Bill Text and History

For
Notification Date
11/13/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Bill 737
Senate Bill 737
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)

Bill Text and History

For
Notification Date
12/4/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.
Senate Joint Resolution 102
Senate Joint Resolution 102
Relating to: observing February 29, 2024, as Rare Disease Day in Wisconsin.

Bill Text and History

For
Notification Date
1/29/2024
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Budget Bill Subjects

Health Services: Departmentwide
Biennial budget bill treatment of matter relating to
Health Services: Departmentwide

Notification Date
2/24/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Insurance: Departmentwide
Biennial budget bill treatment of matter relating to
Insurance: Departmentwide

Notification Date
2/24/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

Topics Not Yet Assigned A Bill Or Rule Number

Mental Health Protections and Parity
Development, drafting or introduction of a proposal relating to
Mental Health Protections and Parity

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/17/2023
First Communication Date
1/10/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.

the application of prescription drug payments for health coverage
Development, drafting or introduction of a proposal relating to
the application of prescription drug payments for health coverage

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/17/2023
First Communication Date
1/10/2023
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has communicated on this matter.

Rare Diseases
Development, drafting or introduction of a proposal relating to
Rare Diseases

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/17/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

2023-25 Biennial Budget Bill
Development, drafting or introduction of a proposal relating to
2023-25 Biennial Budget Bill

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/17/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal has not yet communicated on this matter, but intends to do so at a later date.

2023-25 Biennial Budget Bill
Development, drafting or introduction of a proposal relating to
2023-25 Biennial Budget Bill

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Rare Diseases
Development, drafting or introduction of a proposal relating to
Rare Diseases

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

the application of prescription drug payments for health coverage
Development, drafting or introduction of a proposal relating to
the application of prescription drug payments for health coverage

Action Intended To Affect
Legislative matter

Notification Date
1/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Mental Health Protections and Parity
Development, drafting or introduction of a proposal relating to
Mental Health Protections and Parity

Action Intended To Affect
Both Legislative matter and rule

Notification Date
1/3/2023
First Communication Date
N/A
Communication Information
The principal, a lobbyist authorized by the principal, or another individual acting on behalf of the principal do not intend to communicate on this matter.

Total Lobbying Effort

  2023
January - June
2023
July - December
Total
Total Lobbying Expenditures 2023
January - June
$30,598.87
2023
July - December
$31,326.29
Total $61,925.16
Total Hours Communicating 2023
January - June
15.60
2023
July - December
41.15
Total 56.75
Total Hours Other 2023
January - June
59.95
2023
July - December
80.70
Total 140.65

Percent Allocation of Lobbying Effort

Legislative Bills/Resolutions

Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
25%
2023
July - December
10%
2024
January - June
2024
July - December
Total 16%
Relating to: application of prescription drug payments to health insurance cost-sharing requirements.
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
25%
2023
July - December
10%
2024
January - June
2024
July - December
Total 16%
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
2023
July - December
10%
2024
January - June
2024
July - December
Total 6%
Relating to: regulation of pharmacy benefit managers, fiduciary and disclosure requirements on pharmacy benefit managers, and application of prescription drug payments to health insurance cost-sharing requirements. (FE)
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
2023
July - December
10%
2024
January - June
2024
July - December
Total 6%
Relating to: utilization management controls for prescription drugs to treat mental illness under the Medical Assistance program. (FE)
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
2023
July - December
30%
2024
January - June
2024
July - December
Total 19%
Relating to: utilization management controls for prescription drugs to treat mental illness under the Medical Assistance program. (FE)
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
2023
July - December
30%
2024
January - June
2024
July - December
Total 19%

Budget Bill Subjects

No budget bill subjects found.

Administrative Rulemaking Proceedings

No administrative rulemaking proceedings found.

Topics Not Yet Assigned A Bill Or Rule Number

2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
10%
2023
July - December
2024
January - June
2024
July - December
Total 4%
2023
January - June
2023
July - December
2024
January - June
2024
July - December
Total
2023
January - June
40%
2023
July - December
2024
January - June
2024
July - December
Total 15%

Minor Efforts

No minor efforts found.

Other Matters

No other matters found.

Filed Statements of Lobbying Activity and Expenditures